AbbVie is dedicated to providing innovative cancer therapies targeted to specific molecular pathways. We do this by harnessing the innovation and intellect of our team to bring forth high-impact medicines that offer clinical benefit for cancer patients. We are focused on the discovery and development of targeted therapies that work against the processes cancer cells need to survive.
Our scientists and researchers are committed to discovering world-class therapeutic compounds based on their vast knowledge and expertise in various cancer pathways, particularly apoptosis (programmed cell death1). AbbVie’s research and development team is focused on understanding cancer biology and delivering novel agents that provide a marked improvement in the treatment of numerous forms of cancer.
At the core of our work is the commitment to developing patient-centered innovations. We strive to use our deep expertise in some of the most difficult-to-treat cancers to identify opportunities to create better outcomes for patients at every stage.